Ironwood Pharmaceuticals, Inc. · NASDAQ:IRWD
Armistice Capital, LLC reported a 5.92% stake in Ironwood Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC reported a 5.92% stake in Ironwood Pharmaceuticals, Inc., 9,468,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 5.92%
- Shares
- 9,468,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 5.92% | 9,468,000 |
| Steven Boyd | 5.92% | 9,468,000 |
Source
Related
- Ironwood Pharmaceuticals, Inc.
- Armistice Capital, LLC
- Ironwood Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Form 4 · Denner Alexander J · Sep 17, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Silber Jeffrey · Jul 22, 2026
- Form 4 · Silver Ronald · Jul 9, 2026